Li Kang Biomedical Co Ltd (6242) — Capital Reinvestment Ratio
Li Kang Biomedical Co Ltd (6242) has a Capital Reinvestment Ratio of 0.96x as of December 2025, meaning it reinvests 1% of its operating cash flow (NT$67.23 Million) in capital expenditures (NT$64.75 Million). See Li Kang Biomedical Co Ltd (6242) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Li Kang Biomedical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Li Kang Biomedical Co Ltd's Capital Reinvestment Ratio across 15 annual periods. Check how aggressively does Li Kang Biomedical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Li Kang Biomedical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Li Kang Biomedical Co Ltd from 2002 to 2025. For live market cap and broader valuation context, see 6242 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.58x | NT$92.15 Million | NT$329.54 Million | ▲ +261.2% |
| 2024 | 0.99x | NT$65.38 Million | NT$64.73 Million | ▲ +2837.0% |
| 2023 | 0.03x | NT$96.74 Million | NT$3.26 Million | ▲ +96.4% |
| 2022 | 0.02x | NT$157.24 Million | NT$2.70 Million | ▼ -76.7% |
| 2021 | 0.07x | NT$60.45 Million | NT$4.45 Million | ▲ +219.7% |
| 2020 | 0.02x | NT$81.67 Million | NT$1.88 Million | ▲ +1292.6% |
| 2019 | 0.00x | NT$92.56 Million | NT$153.00K | ▼ -99.8% |
| 2018 | 0.73x | NT$105.53 Million | NT$77.35 Million | ▲ +2623.5% |
| 2017 | 0.03x | NT$110.61 Million | NT$2.98 Million | ▼ -32.8% |
| 2016 | 0.04x | NT$110.82 Million | NT$4.44 Million | ▼ -99.3% |
| 2015 | 5.87x | NT$63.91 Million | NT$375.25 Million | ▲ +3114.8% |
| 2014 | 0.18x | NT$41.66 Million | NT$7.61 Million | ▼ -16.7% |
| 2009 | 0.22x | NT$28.97 Million | NT$6.35 Million | ▼ -93.3% |
| 2003 | 3.28x | NT$5.63 Million | NT$18.50 Million | ▲ +47.1% |
| 2002 | 2.23x | NT$45.87 Million | NT$102.38 Million | — |